Prognostic effect of systemic inflammation in patients undergoing cytoreductive surgery and hyperthermic intrathoracic chemotherapy

Key Points

• To evaluate the prognostic effect of systemic inflammation measured by NLR in patients undergoing specific surgical and chemotherapy procedures.
• Analyzed the association between NLR and patient survival outcomes.
• Compared NLR with other inflammatory markers in prognosis.
• Prioritized pre-treatment NLR for decision-making in treatment.
• NLR was significantly associated with survival outcomes.
• Identified NLR as a distinct prognostic factor compared to other markers.
• Supports the existing literature on the relevance of NLR in clinical practice.